ZimVie Inc. (NASDAQ:ZIMV – Get Free Report) major shareholder Camber Capital Management Lp sold 525,000 shares of the business’s stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $17.71, for a total transaction of $9,297,750.00. Following the transaction, the insider now owns 2,725,000 shares in the company, valued at approximately $48,259,750. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
ZimVie Trading Up 4.0 %
NASDAQ ZIMV opened at $17.72 on Friday. The company’s 50-day moving average price is $18.10 and its 200-day moving average price is $17.53. The company has a current ratio of 1.94, a quick ratio of 1.43 and a debt-to-equity ratio of 0.62. The stock has a market cap of $488.54 million, a PE ratio of -1.27 and a beta of 2.18. ZimVie Inc. has a 12 month low of $6.52 and a 12 month high of $22.40.
ZimVie (NASDAQ:ZIMV – Get Free Report) last posted its quarterly earnings results on Thursday, August 1st. The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.04). The company had revenue of $116.81 million during the quarter. ZimVie had a positive return on equity of 2.21% and a negative net margin of 63.84%. During the same quarter in the previous year, the firm posted $0.17 EPS. Equities research analysts forecast that ZimVie Inc. will post 0.63 earnings per share for the current year.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
Separately, Needham & Company LLC boosted their price objective on shares of ZimVie from $20.00 to $23.00 and gave the company a “buy” rating in a research report on Friday, August 2nd.
Get Our Latest Stock Analysis on ZIMV
ZimVie Company Profile
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Further Reading
- Five stocks we like better than ZimVie
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Owens-Corning Stock: Good Value or Recession Red Flag?
- Insider Buying Explained: What Investors Need to Know
- Datadog Exceeds Q2 Expectations, Solidifies Market Leadership
- Energy and Oil Stocks Explained
- Cybersecurity Stock Surges, Promising Double-Digit Gains
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.